Serine metabolism changes link sphingolipid and one-carbon metabolism to cardiovascular risk factors in a cross-sectional study of asymptomatic adults
This cross-sectional study of asymptomatic adults reveals that serine depletion, driven by increased demands for sphingolipid and transsulfuration metabolism, is mechanistically linked to elevated cytotoxic deoxyceramides and reduced one-carbon metabolites, which are strongly associated with fasting triglycerides and insulin resistance as key cardiovascular risk factors.
Original paper dedicated to the public domain under CC0 1.0 (https://creativecommons.org/publicdomain/zero/1.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
The human body is a vast, interconnected network of chemical reactions, constantly converting food into energy and building blocks for cells. Among these processes, one-carbon metabolism acts like a central hub, shuttling tiny chemical units that are essential for building DNA, repairing tissues, and managing stress. Another critical system involves sphingolipids, a specific type of fat molecule that helps form the protective outer layers of cells and sends signals about when to grow or when to die. For decades, doctors have focused on low-density lipoprotein cholesterol, often called LDL, as the primary indicator of heart disease risk. High levels of this cholesterol are known to clog arteries and lead to heart attacks. However, many people who keep their LDL levels low still suffer from heart problems, suggesting that other hidden chemical shifts are at play long before symptoms appear. Understanding how these different metabolic systems talk to each other in healthy people could reveal the earliest warning signs of future trouble.
Researchers at the University of California, Davis, set out to map these hidden connections in a group of 361 adults who appeared completely healthy. None of the participants had been diagnosed with heart disease, diabetes, or high cholesterol, and they were not taking medication for these conditions. The team wanted to see if subtle changes in the body's chemistry could predict who was moving toward higher risk, even while they felt fine. They analyzed blood samples to measure hundreds of different metabolites, which are the small molecules produced when the body breaks down food and builds new structures. By looking at the patterns in these chemicals, the scientists hoped to find a unifying thread that linked the body's fat metabolism with its amino acid metabolism, the process of handling the building blocks of proteins.
The study revealed a clear pattern: as a person's LDL cholesterol levels rose, even within a range considered normal for many, the balance of specific chemicals in their blood shifted in a coordinated way. The researchers found that people with higher LDL levels had more of certain fats known as ceramides and deoxyceramides. Ceramides are normal fats, but deoxyceramides are slightly different, toxic versions that the body produces when it runs out of a specific ingredient needed to make the right kind of fat. This shortage was traced back to a single amino acid called serine. In the high-risk group, serine levels were lower, while levels of another amino acid called alanine were higher. This imbalance forced the body to use alanine as a substitute when making fats, resulting in the accumulation of those toxic deoxyceramides.
This discovery points to a specific metabolic bottleneck. The body uses serine to build the protective fat layers of cells. When the demand for these fats increases, perhaps due to higher cholesterol levels, the body's supply of serine gets depleted. Without enough serine, the enzyme responsible for building these fats grabs onto alanine instead. This mistake creates the toxic deoxyceramides that can damage cells and contribute to disease. The study showed that this shortage of serine did not just affect fat production; it also rippled through the body's one-carbon metabolism. Because serine is also a key fuel for this system, its depletion meant there was less material available to produce glycine and methionine, other essential amino acids needed for DNA repair and managing oxidative stress. The result was a body under subtle chemical stress, struggling to maintain its defenses.
The researchers also found that this chemical imbalance was more closely tied to triglycerides, a type of fat in the blood often linked to insulin resistance, than it was to LDL cholesterol itself. The ratio of alanine to serine in the blood served as a strong indicator of this metabolic strain. People with a higher ratio had higher triglyceride levels and signs of reduced insulin sensitivity, meaning their bodies were less efficient at processing sugar and fat. This suggests that the alanine-to-serine ratio might be a better early warning sign for residual heart risk than looking at cholesterol numbers alone. It highlights a scenario where the body is working harder to manage its fats, depleting its reserves of serine in the process, and paying the price with toxic byproducts and reduced ability to handle stress.
While the study was conducted on a cross-section of healthy adults and does not prove that changing serine levels will prevent heart disease, it offers a compelling new map of how different metabolic pathways interact. The findings suggest that the risk of heart disease is not just about how much cholesterol is floating in the blood, but also about how the body's internal machinery is coping with the demand to process it. By identifying serine depletion and the resulting rise in toxic fats as a central feature of this process, the study provides a new target for understanding why some people develop heart disease despite having manageable cholesterol levels. Future research will need to determine if restoring serine levels or adjusting the balance of these amino acids can help prevent the accumulation of these harmful fats and protect the heart before clinical disease ever sets in.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.